English
Segment disclosures
Company overviewADAGIO MEDICAL HOLDINGS, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
2 dimension combinations 9 retained observations 6 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Single Reportable Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=adgm:SingleReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-31 – 2024-09-30 | 132000 | USD | 20251112 | Open filing evidence |
| 2024-07-01 – 2024-07-30 | 53000 | USD | 20251112 | Open filing evidence |
| 2024-01-01 – 2024-07-30 | 333000 | USD | 20251112 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 254000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 280000 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 26000 | USD | 20250515 | Open filing evidence |
Single Reportable Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=adgm:SingleReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-31 – 2024-12-31 | 269000 | USD | 20260327 | Open filing evidence |
| 2024-01-01 – 2024-07-30 | 333000 | USD | 20260327 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 300000 | USD | 20250327 | Open filing evidence |